Rare diseases
Investigational molecules
Locations
Back to Portugal679 clinical trials in Senhora Da Hora, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
PortugalStudy on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)
PortugalStudy of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides
PortugalStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
PortugalStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
PortugalStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
PortugalStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
PortugalStudy on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome
PortugalStudy of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments
PortugalStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
PortugalStudy on Tralokinumab and Topical Corticosteroids for Children and Infants with Moderate-to-Severe Atopic Dermatitis
PortugalPortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Alzheimer's disease and associated conditions, including studies on psychosis treatment and cognitive decline prevention. Multiple trials exploring migraine prevention with novel therapeutic approaches.
Studies are evaluating both symptomatic relief and disease modification strategies.
Comprehensive research in breast cancer treatments, particularly focusing on HR+/HER2- variants and innovative combination therapies. Advanced studies in non-small cell lung cancer exploring new treatment paradigms.
Trials emphasize targeted therapies and immunotherapy approaches.
Groundbreaking research in severe asthma management and chronic rhinosinusitis. Studies evaluating new treatments for COPD with focus on long-term safety and efficacy.
Emphasis on innovative inhaler combinations and targeted biological treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
